In a 2020 study published in JAMA Psychiatry, researchers randomly assigned regular flower users to 16% or 24% THC flower (and concentrate users to 70% or 90%). Higher potency within a product type didn’t change how impaired people were on memory and balance tests (observational cohort, Bidwell et al., JAMA Psychiatry, 2020). The cannabis industry has spent a decade running a THC arms race. The research keeps suggesting the number on the label is only part of the story. What actually determines how a cannabis product feels is more interesting than a percentage on a label, and considerably more useful to understand.
🧪 Lab Tested | 👩💼 Woman-Owned | 🏆 Est. 2017
The THC Arms Race and How It Started
Cannabis THC percentages have climbed steadily for decades. In 1995, THC in cannabis seized by the DEA averaged about 4%, and by 2014 it was about 12% (ElSohly et al., Biological Psychiatry, 2016). Legal-market flower today is often labeled above 20%, with some products claiming 30% or higher. Much of the push is market-driven: dispensaries found that customers reliably chose higher-percentage products when given a number to compare. Breeders responded by selecting for THC expression. The percentage became the proxy for quality, and quality became synonymous with strength.
The problem is that THC percentage was never a particularly good proxy for quality, and the research has been trying to say so for years. In the 2020 JAMA Psychiatry study, people who used stronger products had more THC in their blood, yet potency within a product type didn’t change their memory or balance results. Ethan Russo’s 2011 review proposed that terpenes and minor cannabinoids shape how THC feels, the idea now called the entourage effect. It is still a hypothesis in humans.
None of this means THC is irrelevant. It means the percentage on a label is capturing one variable in a multi-variable equation and presenting it as if it’s the whole story.
Tolerance and the CB1 Ceiling Effect
CB1 receptors, the primary targets of THC in the brain, downregulate with consistent exposure. The body literally reduces receptor availability in response to repeated activation. This means two things that work against the high-THC logic.
First, habitual users need progressively higher doses to achieve the same receptor occupancy. But the ceiling isn’t linear. At high tolerance, the relationship between dose and effect flattens significantly. Going from 20% THC flower to 30% THC flower at high tolerance produces a much smaller experiential difference than going from 3% to 10% would produce in a naive user. The marginal return on additional THC decreases as tolerance increases.
Second, a high-tolerance user who switches to a lower-THC product with a richer terpene profile sometimes reports a more satisfying experience than they got from chasing higher numbers. That’s a user report, not a proven mechanism, but it’s an easy one to test on yourself.
For new and low-tolerance users, THC percentage matters significantly. The dose-response curve is steep and the margin between “comfortable” and “too much” is narrow. Starting low regardless of percentage is the correct protocol. But for experienced users making quality comparisons at the top end of the market, chasing the highest THC number is chasing diminishing returns.
Why Terpenes Predict Experience Better Than THC
The entourage effect describes the interaction between cannabinoids and terpenes that shapes the subjective character of cannabis use. Russo’s 2011 paper in the British Journal of Pharmacology is still the most cited foundation for the idea, though controlled human studies are still limited.
Two products with identical THC percentages but different terpene profiles will feel meaningfully different. This is why experienced consumers with access to lab data often describe choosing products based on terpene profile rather than potency.
Myrcene + High THC
Myrcene is the terpene most often linked to heavy, relaxed effects, and people often describe high-myrcene strains as feeling stronger than their THC number suggests. The popular claim that myrcene helps THC cross the blood-brain barrier has no solid human evidence behind it.
Limonene + THC
In animal studies, limonene acted on serotonin and dopamine pathways tied to mood. People often describe high-limonene strains as brighter and less anxious at the same THC level.
Beta-caryophyllene + THC
Beta-caryophyllene binds CB2 receptors directly, a different target from the one behind THC’s high. People often describe caryophyllene-rich strains as feeling smoother in the body.
Terpinolene + THC
People often describe terpinolene-dominant strains as cerebral and alert, even at moderate THC. For a lot of shoppers, the dominant terpene is a better hint at a strain’s character (heady vs. sedating) than its THC number.
A terpene-rich product at moderate THC often feels fuller than a higher-THC product with little aroma, for the people who can tell the difference.
What Minor Cannabinoids Add
THC occupies most of the label, but the minor cannabinoids shape the texture of the experience in ways that raw THC percentage doesn’t capture.
CBD alongside THC
CBD is a negative allosteric modulator at CB1 receptors, which means it reduces the strength of THC’s binding without blocking it. High CBD:THC ratios produce a less intense, more functional psychoactive effect. CBD also acts on 5-HT1A receptors with anxiolytic activity that directly buffers THC-induced anxiety. A product with 15% THC and meaningful CBD will often feel more manageable than a 30% THC isolate product for anxiety-prone users.
CBG alongside THC
CBG acts on alpha-2 adrenoceptors, CB1 receptors (as a partial agonist), and 5-HT1A receptors. In combination with THC, CBG adds a physically comfortable, anxiety-reducing quality that users sometimes describe as a cleaner or clearer version of the THC effect. It’s one reason why some full-spectrum products feel distinctly different from distillate-based products even at the same THC concentration.
CBN alongside THC
CBN appears in aging cannabis as THC oxidizes. It’s associated with sedating, sleep-adjacent effects in combination with THC. A product high in CBN relative to other minor cannabinoids tends to produce heavier body effects. CBN isn’t about potency; it’s about the direction the effect takes.
THC in isolation
Distillate is refined for clean, consistent THC, with terpenes added back for flavor, which makes it easy to dose. Live resin keeps the plant’s own terpene and minor cannabinoid profile, and many experienced users say that’s what gives it extra depth.
When THC Content Actually Does Matter
- New and low-tolerance users. For someone with no established CB1 tolerance, the dose-response curve is steep and the threshold for uncomfortable effects is low. THC percentage matters a lot here because small differences in milligrams produce large differences in experience. The correct protocol is to start with the lowest THC concentration available, regardless of terpene profile.
- Edibles with precise dosing needs. When the delivery format is an edible and you need predictable dosing, THC milligrams per serving is the number that matters. Edible onset is slow, the dose commits at ingestion, and small milligram differences compound over time. The COA milligram-per-serving figure is the critical data point for edible safety and predictability.
- Therapeutic use at meaningful doses. Some users incorporate cannabis products into pain, sleep, or symptom management routines where a certain threshold of CB1 activation is required. For these users, the minimum effective THC dose matters and choosing a product below it won’t achieve the intended effect. This is a case where THC concentration is a real clinical variable.
- Comparing products within the same format and terpene class. If two products have identical terpene profiles and you’re choosing between 18% and 22% THC, the higher percentage will likely produce a stronger effect. THC percentage is a useful differentiator when all other variables are held constant. The problem is that they rarely are in real-world purchasing decisions.
What to Look at on a COA Instead
Dominant terpene: Often a better hint at effect character than THC percentage. Myrcene-dominant = body relaxation, sedation-leaning. Limonene-dominant = mood uplift, sativa-leaning. Terpinolene-dominant = cerebral, heady. Beta-caryophyllene prominent = physical comfort, anti-anxiety. Terpene data isn’t on every COA (ours cover potency and purity, and our terpene supplier tests the terpenes), so the strain’s aroma and description are a good guide too.
Total terpene percentage. Beyond the dominant terpene, total terpene content gives a rough sense of how aromatic and full a product will be: the higher it is, the more flavor you’ll usually get. Live resin keeps more of the plant’s original terpenes, and experienced users who can tell the difference usually attribute it to this.
Cannabinoid ratio (not just THC percentage). How much CBD, CBG, or CBN is present alongside the THC tells you about the character of the CB1 activation, not just the intensity. A 1:1 CBD:THC ratio product produces a fundamentally different experience from a pure THC product at the same concentration. These ratios appear in the cannabinoid panel and are often more meaningful than the THC number alone.
Format and extraction method. Live resin preserves terpenes through rapid low-temperature processing immediately after harvest. Distillate is refined for purity and consistency, with terpenes added back. For vape products, the label “live resin” or “live rosin” is a meaningful quality signal that often correlates with better terpene retention. It’s a production method claim, so buy from brands that test every batch and post the COAs.
Every TribeTokes batch is third-party tested for potency, our raw materials are full-panel tested for purity (solvents, pesticides, heavy metals, mycotoxins, microbials), and the COAs are on our lab results page. For a full guide on reading what each section of a COA means, see How to Read Cannabis Lab Results (COA).
Frequently Asked Questions
Not reliably. A 2020 study in JAMA Psychiatry randomly assigned regular users to 16% or 24% THC flower, and the higher-potency group didn’t show more impairment on memory and balance tests. Terpene profile, minor cannabinoid content, tolerance level, and consumption format all affect the experience more consistently than THC percentage alone at the upper end of the potency range.
For new and low-tolerance users, yes. The difference matters because the dose-response curve is steep early. For experienced users with established tolerance, the difference is often negligible. CB1 receptor downregulation flattens the relationship between THC concentration and effect intensity at high tolerance. The marginal experiential difference between 20% and 30% THC at high tolerance is much smaller than the difference between 5% and 15% at low tolerance.
The entourage effect describes the synergistic interaction between cannabinoids and terpenes that shapes the character of the cannabis experience. Terpenes are not passive flavor compounds. They interact with serotonin, dopamine, GABA, and CB2 receptors in ways that modify how THC feels. People often describe myrcene as sedating, limonene as uplifting and beta-caryophyllene (which binds CB2) as smoothing. The idea is that the combined profile feels different from THC alone; it is still being tested in humans.
Terpene profile is the most common explanation. Strains high in myrcene are often described as heavier than their THC number suggests (the blood-brain barrier explanation you’ll see online isn’t backed by human research). Tolerance, dose and format matter too, and live resin keeps more of the plant’s original terpenes, which many people describe as a fuller effect.
The dominant terpene is the single most predictive data point for effect character. Total terpene percentage indicates how much entourage effect is available. The cannabinoid ratio (how much CBD, CBG, or CBN is present alongside THC) shapes the character of CB1 activation. For inhaled products, a live resin designation is a better quality signal than a high THC percentage on its own.
CBD acts as a negative allosteric modulator at CB1 receptors, which reduces the maximum binding strength of THC without blocking it. The practical effect at typical 1:1 or 2:1 CBD:THC ratios is a less intense but often more functional and less anxiety-prone experience. CBD also has its own 5-HT1A anxiolytic activity that directly counteracts one of the most common adverse effects of THC. For anxiety-prone users, meaningful CBD alongside THC often produces a more manageable experience than equivalent THC alone.
Live resin preserves the terpene profile of the fresh plant through rapid low-temperature processing. Distillate removes terpenes to produce a purer, more shelf-stable concentrate. For users who experience the entourage effect, live resin products often feel more satisfying at equivalent THC concentrations because the terpenes are intact. Distillate products are more consistent batch-to-batch and carry higher THC concentrations, which may matter for precise edible dosing. Neither is categorically better. The right choice depends on what the user values.
Because consumers buy it. THC percentage is often the first number shoppers compare, even experienced ones. Dispensaries stock what sells. Breeders develop what dispensaries order. The percentage climbed not because it consistently improves the experience but because it consistently improves the sale. The research is catching up to what some experienced users and growers have known for a while: terpene quality and cannabinoid ratio tell a more complete story than a single number.
THC Is One Number. We Post the COA for Every Batch.
Third-party tested. ISO-accredited lab. COA on every batch.